Evidence map›Paper›PMID 36074175›Full record

ArticleDysphagia2023

The Impact of Obesity on the Fibrostenosis Progression of Eosinophilic Esophagitis in a U.S. Veterans Cohort.

Alexa Trovato, Tyler Tsang, Nihita Manem, Katherine Donovan, Darren E Gemoets, Christopher Ashley, Evan S Dellon, Micheal Tadros

Abstract read
PubMed Publisher
In one paragraph

Article in Dysphagia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Development and Validation of the Veterans Affairs Eosinophilic Esophagitis Cohort.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alexa TrovatoAlbany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Tyler TsangAlbany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Nihita ManemAlbany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Katherine DonovanAlbany Medical College, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Darren E GemoetsAlbany Stratton VA Medical Center, 113 Holland Ave, Albany, NY, 12208, USA.
Christopher AshleyAlbany Stratton VA Medical Center, 113 Holland Ave, Albany, NY, 12208, USA.
Evan S DellonDivision of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, CB#7080, 130 Mason Farm Rd, Chapel Hill, NC, 27599-7080, USA.
Micheal TadrosAlbany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA. Tadrosm1@amc.edu.ORCID 0000-0003-3118-3893
Albany Medical Center Hospital · USAlbany Stratton VA Medical Center Albany · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether obesity is protective against progression of EoE is unknown. The aim of this study was to assess factors that alter the progression of EoE and determine if BMI is correlated with reduced disease severity. In this retrospective analysis of the Department of Veterans Affairs electronic health records, patients with EoE who received at least one dilation were identified using ICD and CPT codes. Kaplan-Meier curves determined the relationship between BMI and time to second esophageal dilation as a measurement of severity of disease. Cox proportional hazards models assessed the risk of second dilation adjusted for potential confounders. Of 2890 patients with EoE and at least one dilation, 40% were obese (n = 1165). There were no clinically significant differences in demographics between obese and non-obese patients. Non-obese patients were more likely to be smokers and had a higher mean average of the number of dilation visits compared to obese patients (p < 0.05). When stratified by obesity, non-obese individuals had a median time to next dilation of 6.53 years (95% CI (5.83, 7.79)) compared to 9.24 years for obese individuals (95% CI (7.40, 15.04)). When stratified by six BMI categories, median time to second dilation increased with increasing BMI. The hazard ratio of second dilation for obese individuals was 0.81 (95% CI (0.72-0.92)). EoE patients with a higher BMI were less likely to undergo a second dilation compared to those with a lower BMI. Obesity may have a protective role in EoE or severe strictures may lead to malnourishment. Further research into these possibilities is needed.

Indexed as

Eosinophilic EsophagitisEsophageal StenosisVeteransEnteritisEosinophiliaGastritisHumansObesityRetrospective StudiesDilationEosinophilic esophagitisEsophageal diseaseEsophageal strictureObesity

Identifiers

PMID36074175
OpenAlexW4294991728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.